The biotech has launched a strategic review to consider options, including a possible sale, following shareholder pressure.

The UK's MHRA has been redesignated as one of the WHO’s collaborating centres for the standardisation and evaluation of ...

Tempest Therapeutics is eyeing a strategic partner to continue amezalpat’s development amid ‘unavailable capital markets.’ ...

On 7 April, at the 2025 American Academy of Neurology (AAN) meeting, a poster presentation by the Peking Union Medical ...

APHA executive director Dr Georges C Benjamin has called for HHS secretary Robert F Kennedy, Jr (RFK Jr) to "resign or be ...

The FDA has granted approval for the injectable antibiotic, Piperacillin and Tazobactam, to be used in B Braun's drug ...

PharmaLogic is set to acquire a majority stake in Agilera Pharma to generate the CDMO focusing on radiopharmaceutical ...